EP0586451A1 - Hemmung der glatten muskelzellenproliferation durch vitronektin - Google Patents

Hemmung der glatten muskelzellenproliferation durch vitronektin

Info

Publication number
EP0586451A1
EP0586451A1 EP92910615A EP92910615A EP0586451A1 EP 0586451 A1 EP0586451 A1 EP 0586451A1 EP 92910615 A EP92910615 A EP 92910615A EP 92910615 A EP92910615 A EP 92910615A EP 0586451 A1 EP0586451 A1 EP 0586451A1
Authority
EP
European Patent Office
Prior art keywords
vitronectin
smooth muscle
smc
pdgf
extended form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP92910615A
Other languages
English (en)
French (fr)
Inventor
Errol Wijelath
Catherine Demoliou-Mason
Sibylle Hess
Klaus Theodore Preissner
Vijay Vir Kakkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Thrombosis Research Institute
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Thrombosis Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV, Thrombosis Research Institute filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of EP0586451A1 publication Critical patent/EP0586451A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
EP92910615A 1991-05-28 1992-05-27 Hemmung der glatten muskelzellenproliferation durch vitronektin Withdrawn EP0586451A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9111439 1991-05-28
GB919111439A GB9111439D0 (en) 1991-05-28 1991-05-28 Inhibition of vascular smooth muscle cell proliferation

Publications (1)

Publication Number Publication Date
EP0586451A1 true EP0586451A1 (de) 1994-03-16

Family

ID=10695684

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92910615A Withdrawn EP0586451A1 (de) 1991-05-28 1992-05-27 Hemmung der glatten muskelzellenproliferation durch vitronektin

Country Status (6)

Country Link
EP (1) EP0586451A1 (de)
AU (1) AU1763792A (de)
GB (2) GB9111439D0 (de)
IE (1) IE921697A1 (de)
WO (1) WO1992021363A1 (de)
ZA (1) ZA923901B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960474B2 (en) 2006-03-24 2011-06-14 Henkel Ag & Co. Kgaa High strength adhesives with impact peel strength

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
ATE406909T1 (de) * 1993-05-13 2008-09-15 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292663B1 (de) * 1987-05-25 1995-06-14 Research Development Corporation Of Japan Verfahren zur Herstellung von Vitronectin
US4945086A (en) * 1988-05-03 1990-07-31 The Board Of Trustees Of The Leland Stanford Junior University Smooth muscle cell growth inhibitor
JPH0651638B2 (ja) * 1989-02-13 1994-07-06 新技術事業団 角膜上皮創傷治療用点眼剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9221363A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960474B2 (en) 2006-03-24 2011-06-14 Henkel Ag & Co. Kgaa High strength adhesives with impact peel strength

Also Published As

Publication number Publication date
WO1992021363A1 (en) 1992-12-10
AU1763792A (en) 1993-01-08
GB9120748D0 (en) 1991-11-13
ZA923901B (en) 1993-03-08
IE921697A1 (en) 1992-12-02
GB9111439D0 (en) 1991-07-17

Similar Documents

Publication Publication Date Title
Ashizawa et al. Osteopontin is produced by rat cardiac fibroblasts and mediates A (II)-induced DNA synthesis and collagen gel contraction.
Hajjar et al. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells.
JP2961708B2 (ja) 成長ホルモンとインスリン様成長因子―１の組み合わせが成長を増進する
EP0835115B1 (de) 4-(2-(n-(-2-carboxamidoindole)aminiethyl)-benzensulfonamide oder sulfonylharnstoffe als pdgf antagoniste
US9254300B2 (en) Elastin protective polyphenolics and methods of using the same
EP1333853B1 (de) Wachstumsfaktorkomplex
CN101146547A (zh) 肌肉生长抑制素（gdf-8）拮抗剂用于增进创伤愈合和防止纤维变性疾病的用途
JP2004043507A (ja) 細胞外マトリックスの蓄積を防止するためのトランスフォーミング増殖因子βの阻害
US20060264375A1 (en) Elastin protective polyphenolics and methods of using the same
US6689746B2 (en) Use of isolated domains of type IV collagen to modify cell and tissue interactions
US5155038A (en) Use of thrombospondin to promote wound healing
CN101300269A (zh) 机械生长因子肽及其用途
Yao et al. Combined thromboxane A2synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations
EP0586451A1 (de) Hemmung der glatten muskelzellenproliferation durch vitronektin
CA2318432C (en) The use of isolated domains of type iv collagen to modify cell and tissue interactions
US7858577B2 (en) Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2
JP2002539267A (ja) 瘢痕および癒着形成を制限するための方法
JP2014043461A (ja) 血管硬化症の治療における使用のためのｂｍｐ−７
US7517654B2 (en) Peptide and a derivative thereof promoting cell adhesion and spreading
WO2003094910A1 (en) Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
Cechowska Pasko et al. Alterations in glycosaminoglycans in wounded skin of diabetic rats. A possible role of IGF-I, IGF-binding proteins and proteolytie activity
US7364722B2 (en) Pharmaceutical and cosmetic compositions comprising plgf-1
Guth et al. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo
JPH07316066A (ja) 創傷治癒剤
US8114829B2 (en) Elastin protective polyphenolics and methods of using the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19931217

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19941115